1
Biologically compatible polymers, namely hydrogels used to produce polymeric networks for use in the manufacture of engineered living tissue for medical, scientific and non-scientific purposes; Cell culture medium for use in the biotechnology industry; Cell culture medium for use in non-medical research laboratories; Biological preparations for use in cell cultures, other than for medical or veterinary use; Engineered living tissue and tissue collections, namely human and animal organs, connective tissue, epithelial tissue, muscular tissue and nerve tissue, and tissue collections, for scientific and research use and Medical research; Biologically compatible materials, namely hydrogels used to produce polymeric networks for use in the manufacture of living tissue; Proteins in the form of raw materials for scientific and medical research
5
Pharmaceutical preparations for use in the field of 3D bioprinting of tissue and organs; Pharmaceutical preparations based on cellulose nanofibril for use in 3D bioprinting tissue and organs; Tissue-regenerative pharmaceutical preparations; Cells for medical use; Human allograft tissue; Living cells for medical use; Implantation of living tissue with controlled tissue regeneration; Live tissue implants; Implantable materials consisting of living tissue for use in controlled tissue regeneration; Skin grafts; Surgical implants comprised of living tissues; Surgical implants obtained from stem cells; Transdermal patches for use in creating skin for prosthetics and skin grafts; Live tissue for grafts; Engineered biological tissue and organs, namely human and animal cardiovascular, lung, digestive, hepatobiliary, urological, renal, endocrine, epithelial, muscular and nerve tissue and organs, for medical purposes; Biological molecules to aid tissue development; Haemostatic gel matrix preparations for treating wounds; Natural biomaterial for bone, blood and tissue growth for medical purposes; Pharmaceutical preparations for regeneration, repair and treatment of both human and animal tissue; Pharmaceutical preparations for the treatment of bone diseases, For cartilage diseases, blood vessel diseases, nerve cell degeneration, tendon and ligament degeneration, retina degeneration, kidney degeneration; Soft tissue degeneration, diseases involving abnormal cell growth; Natural biomaterial for bone grafting; Natural biomaterial for grafting cartilage; Biological tissue cultures for medical purposes; Biological tissue cultures for medical purposes; Biological tissue transplants; Biological bone and skin tissue impregnated with oxygen lines, enabling the relevant tissue structures to increase cell survival in tissue intended for subsequent implant; Gene therapy products, Namely, Genetically engineered tissue for transplantation; Implantable frames containing live tissue for maintaining tissue structure; Natural biomaterial for bone and tissue growth for medical purposes